Open Access
Table 2
Serologic and clinical findings in infants with congenital toxoplasmosis born to treated and untreated mothers in the United States.
| No. of infants aged 0–180 days*
|
p value | (95% CI) | |||
|---|---|---|---|---|---|
| Treated (n = 25) | Untreated (n = 164) | ||||
| Serologic findings | IgM(+)/IgM performed (%) | 11/25 (44) | 142/164 (86.6) | <0.001 | (0.04–0.3) |
| IgA(+)/IgA performed (%) | 15/25 (60) | 127/164 (77.4) | 0.06 | (0.18–1.05) | |
| IgE(+)/IgE performed (%) | 3/16 (18.7) | 41/102 (40.2) | 0.1 | (0.09–1.28) | |
| Eye disease/n (%) | 10/16 (62.5) | 119/129 (92.2) | 0.003 | (0.04–0.46) | |
| Clinical findings | Cerebral calcifications/n (%) | 13/17 (76.5) | 94/118 (79.7) | 0.75 | (0.24–2.77) |
| Hydrocephalus/n (%) | 5/13 (38.5) | 67/99 (67.7) | 0.039 | (0.09–0.98) | |
| E + C + H/n (%) | 3/11 (27.3) | 53/86 (61.6) | 0.048 | (0.05–0.94) | |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.